We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Michael
Sykes
michael.sykes@northumbria.ac.uk
Dr
Michael
Sykes
michael.sykes@northumbria.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Diabetes mellitus
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Why do we want to do this study?
People with diabetes who have raised blood sugar level are at increased risk of complications such as sight loss, kidney disease and nerve damage. National guidelines recommend insulin pumps for people with type 1 diabetes who have high blood sugar. 90,000 people with type 1 diabetes in England have high blood sugar but do not use an insulin pump. People with diabetes, healthcare professionals and NHS England have all said that increasing insulin pump use is important.
The National Diabetes Audit measures how many people with diabetes receive guideline-recommended care. We think that we can increase insulin pump use by supporting specialist diabetes teams (doctors, nurses and others) to use National Diabetes Audit feedback more effectively. We have developed and tried a programme of workshops, coaching and sessions where teams learn from each other. The programme, which we have called a Quality Improvement Collaborative, will be delivered virtually and will be free to the teams.
The aim of this study is:
To explore how people engage with, and respond to, the National Diabetes Audit Quality Improvement Collaborative.
Who will be eligible and what will the study involve?
All diabetes teams will be offered the 15-month support programme. Participating teams will be randomly assigned to get the support from January 2023 or from July 2024. We will sample approximately 42 teams. We will interview doctors, nurses and others from both the 2023 group and those who will be part of the 2024 group. We will observe what happens during the programme and read documents that are produced.
Our findings will help the National Diabetes Audit, and others, decide how to support teams to improve.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
None
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Michael
Sykes
michael.sykes@northumbria.ac.uk
Dr
Michael
Sykes
michael.sykes@northumbria.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Northumbria at Newcastle and funded by NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 53883
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
